Grail: Marissa Song
Grail has appointed Marissa Song as its general counsel and corporate secretary. Prior to Grail, Song worked at Gilead Sciences for 14 years, where she most recently served as VP of corporate legal. Before Gilead, Song was a corporate associate at Latham & Watkins LLP. She also currently serves on the board of the Disability Rights Legal Center.
Meridian Bioscience: Bryan Baldasare
Meridian has appointed Bryan Baldasare as its CFO. Baldasare is currently the firm's executive VP and chief accounting officer. He previously served as interim CFO, corporate controller, and treasurer. Prior to joining Meridian in 2000, Baldasare served as senior audit manager at Arthur Andersen LLP.
NanoString Technologies: Mark Winham
Nanostring Technologies has appointed Mark Winham as senior VP of operations. Winham worked for more than 10 years in manufacturing for Applied Biosystems and Life Technologies, serving in roles including senior director and VP of global manufacturing. More recently, he served as CSO at Wamberg Genomic Advisors. Prior to that, he was chief operating officer for Human Longevity, and also previously served as COO of Millennium Health.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.